Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
Titel:
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
Auteur:
Tewari, Krishnansu S Sill, Michael W Penson, Richard T Huang, Helen Ramondetta, Lois M Landrum, Lisa M Oaknin, Ana Reid, Thomas J Leitao, Mario M Michael, Helen E DiSaia, Philip J Copeland, Larry J Creasman, William T Stehman, Frederick B Brady, Mark F Burger, Robert A Thigpen, J Tate Birrer, Michael J Waggoner, Steven E Moore, David H Look, Katherine Y Koh, Wui-Jin Monk, Bradley J